Oryzon Genomics, S.A. is a clinical stage biopharmaceutical company and the European leader in the development of epigenetics-based therapeutics, with a strong focus on personalized medicine approaches to CNS disorders and oncology.
Oryzon has a broad and growing portfolio, with two compounds in clinical trials: iadademstat, a highly potent and selective LSD1 inhibitor, in Phase IIa clinical trials for the treatment of acute myeloid leukemia and small cell lung cancer, and vafidemstat, a CNS optimized LSD1 inhibitor in multiple Phase II trials for the treatment of CNS and psychiatric diseases. Phase IIb trials for both compounds are under preparation. Our pipeline also includes ORY-3001, a selective LSD1 inhibitor in preclinical development for the treatment of non-oncological diseases, and additional programs for developing inhibitors against other epigenetic targets. Oryzon has a strong technological platform for biomarker identification and performs biomarker and target validation for a variety of malignant and neurological diseases.
Oryzon has been listed on the Spanish Stock Exchange since December 2015 (ORY, ISIN Code: ES0167733015). Since then, the company has attracted specialized investors from US, Israel and Europe in several PIPEs led by different US investment banks.
The company was founded in 2000 and has offices in Spain and the United States.
Company Details
- Employees
- 58
- Founded
- -
- Address
- Calle De Sant Ferran, 74, Cornellà De Llobregat,catalonia 08940,spain
- Phone
- 34 93 515 13 13
- in****@****zon.com
- Industry
- Biotechnology
- Website
- oryzon.com
- Keywords
- Drug discovery and development, biomarker discovery, cancer, neurodegeneration, epigenetics, clinical trials.
- HQ
- Cornellà de Llobregat, Catalonia
Oryzon Genomics Sa Questions
Oryzon Genomics Sa's helpline number is 34 93 515 13 13
Oryzon Genomics Sa's website is oryzon.com
Oryzon Genomics Sa's LinkedIn profile is https://www.linkedin.com/company/oryzon
Oryzon Genomics Sa has
58 employees.
View email and phone details for 58
employees at Oryzon Genomics Sa.
Oryzon Genomics Sa's industry is
Biotechnology
Oryzon Genomics Sa's top competitors are
Sequentia Biotech,
Flomics,
Aelix Therapeutics,
Minoryx Therapeutics,
Nuage Therapeutics,
Ona Therapeutics,
Splicebio,
Almirall,
Peptomyc,
Onechain Immunotherapeutics.
Oryzon Genomics Sa's support email address is info@oryzon.com
Oryzon Genomics Sa's categories are Biotechnology
Oryzon Genomics Sa's founding year is 2000
